Achieve Life Sciences, Inc. (ACHV) income statement
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.61+0.23 (+3.53%)
Close on Oct 19, 2026Market cap $679.67MP/E –Yield –
Achieve Life Sciences, Inc. financial ratios
See a number that looks wrong?